<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3001256782
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1981
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRIVASTAL RETARD 50MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PIRIBEDIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        31.7
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SERVIER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SERVIER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SERVIER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N04BC08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group - ATC Code: N04BC08</p><p>&nbsp;</p><p>TRIVASTAL 50 mg LP, prolonged-release coated tablet is a dopamine agonist (that acts in the brain to stimulate the receptors of a substance called dopamine).</p><p><strong>This </strong><strong>medicine</strong><strong> is indicated:</strong></p><p>For the treatment of certain forms of Parkinson&#39;s disease.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use </strong><strong>TRIVASTAL </strong><strong>50 mg </strong><strong>LP, </strong><strong>prolonged-</strong><strong>release coated tablet in the following </strong><strong>cases</strong><strong>:</strong></p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->history of allergy to piribedil, or any of the other ingredients in this medicine listed in section 6.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->myocardial infarction or other serious cardiovascular disease,</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->in combination with anti-emetic neuroleptics (see Other medicinal products and TRIVASTAL 50 mg LP, sustained-release coated tablet),</p><p>If you are in any doubt, you must ask your doctor or pharmacist for advice.</p><p>&nbsp;</p><p><strong>Precautions for use</strong><strong> and</strong><strong> special warnings</strong></p><p>Ask your doctor before taking TRIVASTAL 50 mg LP, sustained-release coated tablet</p><p>&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp; <!--[endif]-->if you have (have had) or develop a medical condition or symptoms, in particular kidney disease, liver disease, swelling of legs, feet or fingers.</p><p><!--[if !supportLists]-->&middot;&nbsp; <!--[endif]-->If you or someone close to you notices that you get confused/disorientated, agitated, aggressive, or that you develop mental problems such as delirium, delusions, or hallucinations. Your doctor may need to adjust the dose or discontinue the treatment&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp; <!--[endif]-->If you or someone close to you has noticed that you present unusual urges or compulsive behaviour and that you cannot resist the impulse, the need or the temptation to perform certain activities which could harm you or those around you, talk to your doctor. These are impulse control disorders that can include gambling addiction, uncontrollable and excessive eating or spending, abnormally high libido or an increase in ideas and desires with a sexual connotation. Your treatment may be modified or stopped if your doctor deems it necessary.</p><p>In the event of excessive drowsiness or sudden onset of sleep during your treatment with TRIVASTAL, you must contact your doctor.</p><p>Your blood pressure should be checked regularly particularly at the start of treatment in order to avoid orthostatic hypotension (a drop in pressure while standing up).</p><p>In elderly subjects, the risk of falls, whether related to hypotension, sudden sleep onset or delirium, must be taken into account.</p><p>It is preferable to take the tablets after meals.</p><p>&nbsp;</p><p><strong>Children and adolescents</strong></p><p>TRIVASTAL is not recommended in children and adolescents under 18 years of age.</p><p>Check with your doctor or pharmacist if you are not sure.</p><p><strong>Other medicinal products and </strong><strong>TRIVASTAL </strong><strong>50 mg LP, </strong><strong>sustained-release coated tablet</strong></p><p>This medicine must not be used in combination with certain medicines (<u>see </u><u>Do not use </u><u>TRIVASTAL </u><u>50</u><u> </u><u>mg </u><u>LP, </u><u>sustained -</u><u>release coated tablet</u>).</p><p>In order to avoid possible interactions between several medicines, &nbsp;particularly neuroleptics (excluding clozapine), tetrabenazine, some medicines used for the prevention of nausea and vomiting, and sedatives, you should always tell your doctor or pharmacist about any other treatment you are taking.</p><p><strong>TRIVASTAL </strong><strong>50 mg LP, </strong><strong>sustained -release coated tablet</strong><strong> with food, drinks and alcohol</strong></p><p>The consumption of alcohol or alcoholic beverages is inadvisable if you take this medicine. The effects could be increased.</p><p>&nbsp;</p><p>Pregnancy and breast-feeding</p><p>In the absence of relevant data, the use of this drug during pregnancy and breastfeeding is not recommended.</p><p>If you are pregnant or breastfeeding, if you think you are pregnant or are planning a pregnancy, ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines</strong></p><p>TRIVASTAL may induce drowsiness and sudden sleeping fits.</p><p>If this happens, you must not drive or do anything where any impairment of your alertness could expose you or other people to the risk of a serious accident or death (for example operating machinery) until the disappearance of such effects.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Due to the presence of sucrose, this medicine must not be used in case of fructose intolerance, glucose and galactose malabsorption syndrome or sucrase-isomaltase deficiency (rare metabolic disorders).</p><p>&nbsp;</p><p>HOW TO USE TRIVASTAL 50 mg sustained-RELEASE COATED TABLET?</p><p><strong>&nbsp;</strong></p><p><u>Posology</u></p><p>The dosage is strictly individual and is established by your doctor.</p><p>To avoid the risk of impulse control disorders (explained in section 2), your doctor may need to adjust the dose or discontinue the treatment, if you experience any symptoms.</p><p>Always take the medication exactly as your doctor has told you.</p><p>&nbsp;</p><p>Method of administration</p><p>Oral route.</p><p>Frequency of administration</p><p>The tablets should be swallowed, without chewing, with half a glass of water at the end of the meal.</p><p><u>Duration of treatment</u></p><p>Comply with your doctor&rsquo;s prescription.</p><p>Do not stop taking the treatment without medical advice.</p><p>&nbsp;</p><p><strong>If you take more TRIVASTAL 50</strong><strong>&nbsp;</strong><strong>mg </strong><strong>LP, sustained-</strong><strong>release coated tablet </strong><strong>than</strong><strong> you should: </strong></p><p>Consult your doctor or pharmacist immediately.</p><p>Inform your doctor immediately in case of massive ingestion.</p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking</strong> <strong>TRIVASTAL 50&nbsp;mg sustained-release coated tablet</strong>:</p><p>Do not discontinue your treatment with TRIVASTAL without speaking to your doctor beforehand. If you need to stop taking this medicine, your doctor will reduce the doses gradually in order to reduce the risk of worsening the symptoms. You must not discontinue TRIVASTAL suddenly. Sudden discontinuation may result in the onset of a condition known as neuroleptic malignant syndrome which may represent a major risk for your health. The symptoms include:</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->akinesia (difficulty in performing movements);</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->muscle stiffness;</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->fever;</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->unstable blood pressure;</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->tachycardia (increased heart rate), see section 3;</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->confusion;</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->decreased level of consciousness (e,g, coma).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, TRIVASTAL 50&nbsp;mg LP, sustained -release coated tablet can cause side effects, although not everybody gets them.</p><p>The frequency of the possible side effects listed below is defined using the following system:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Very common (affects more than 1 in 10 users)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Common (affects 1 to 10 in 100 users)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Uncommon (affects 1 to 10 in 1000 users)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Rare (affects 1 to 10 in 10,000 users)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Very rare (affects fewer than 1 in 10,000 users)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Not known (frequency cannot be estimated from the available data)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Common side effects:</strong></p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Minor digestive disorders (nausea, vomiting, flatulence), which may be reduced by progressively increasing the dosage,</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Confusion, hallucination (<u>visual, auditory, mixed</u>) or agitation that disappear when treatment is stopped,</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Dizzy sensation that disappears when treatment is stopped;</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Drowsiness.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Uncommon side effects:</strong></p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Hypotension, orthostatic hypotension (decrease in blood pressure when you stand up), blood pressure instability, which may be accompanied by dizziness or malaise.</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Very rare side effects:</strong></p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Excessive drowsiness during the day, sudden sleep fits.</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Incapacity to resist the impulse, need or temptation to carry out an action which could be harmful for you or those around you that may include:</p><p><!--[if !supportLists]-->&sect;&nbsp; <!--[endif]-->A strong compulsion to gamble (money) in an excessive manner in spite of serious personal or familial consequences,</p><p><!--[if !supportLists]-->&sect;&nbsp; <!--[endif]-->An increase or change that is worrying for you or those around you in the interest in sex or sexual behaviour, for example an increase in sex drive.</p><p><!--[if !supportLists]-->&sect;&nbsp; <!--[endif]-->Excessive and compulsive spending or shopping.</p><p><!--[if !supportLists]-->&sect;&nbsp; <!--[endif]-->Eating in an excessive manner (eating large amounts of food over a short period) or eating compulsively (eating more food than usual and beyond the hunger sensation).</p><p>You may also encounter the following side effects:</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->Aggression</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->Psychiatric disorders (delusion, delirium),</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->Swelling of the legs, feet or fingers</p><p><!--[if !supportLists]-->&bull;&nbsp; <!--[endif]-->Dyskinesia (abnormal movements)</p><p>If you experience any side effects, contact your doctor.</p><p>Risk of allergic reactions due to the presence of Cochineal red A (E124) and sodium.<br />Due to the presence of sucrose, this medicine must not be used in case<br />of fructose intolerance, glucose and galactose malabsorption syndrome<br />or sucrase-isomaltase deficiency (rare metabolic disorders).<br />Due to the presence of cochineal red A (E124), there is a risk of<br />allergic reactions.<br />This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any pssible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the box.</p><p>Do not store above 25&deg;C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if !supportLists]-->&middot;&nbsp; <!--[endif]-->The active substance is:</p><p>Piribedil......................................................................................................................................... 50.00 mg</p><p>For one prolonged-release coated tablet.</p><p><!--[if !supportLists]-->&middot;&nbsp; <!--[endif]-->The other ingredients are:</p><p>Povidone, magnesium stearate, talc, sodium hydrogen carbonate, carmellose sodium, white beeswax, titanium dioxide (E171), cochineal red A aluminium lake (E124), polysorbate 80, sucrose, anhydrous colloidal silica.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicinal product is available in the form of prolonged-release
coated tablets. Box of 10, 20, 30, 40, 50, 60 or 100.
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Name of the marketing authorisation holder <strong>&nbsp;</strong></p><p><strong>LES LABORATOIRES SERVIER</strong></p><p>50, rue Carnot</p><p>92284 SURESNES Cedex</p><p>FRANCE</p><p>&nbsp;</p><p>Manufacturer</p><p><strong>LES LABORATOIRES SERVIER Industrie </strong></p><p>905, route de Saran</p><p>45520 GIDY</p><p>France</p><p>&nbsp;</p><p>For more information about this medicine, please contact the local representative of the Marketing Authorisation Holder.</p><p>&nbsp;</p><p><strong>Saudi</strong><strong> Arabia</strong></p><p>Servier Saudi Arabia Scientific Office<br />3533 Al Hawiy - Hitteen Dist.<br />1st floor - Office #101<br />Kingdom of Saudi Arabia<br />Tel.: +966 011 252 2330<br />E-mail: regulatory.sa1@servier.com</p><p>&nbsp;</p><p><strong>Gulf</strong><strong> </strong><strong>Countries</strong></p><p>Les Laboratoires Servier Scientific Office</p><p>P.O. Box 1586, level 15, Arenco Tower, Dubai Media City, Sheikh Zayed Road, Dubai, UAE</p><p>Tel: +971 4 3329903</p><p>E-mail: magdy.abdou@ servier.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Date of last revision of the leaflet:  02.2023.

To report any side effect(s):
 Saudi Arabia:
- National Pharmacovigilance Center (NPC)
-Fax: +966- 11- 205- 7662
- SFDA call Center 19999
-Toll Free Phone:8002490000
- E-mail: npc.drug@sfda.gov.sa
- Website: https://ade.sfda.gov.sa/
 Other GCC states:
- Please contact the relevant competent authority.

f. Council of Arab Health Ministers:
This is a Medicament
Medicament is a product which affects your health and its
consumption contrary to instructions is dangerous for you.
- Follow the doctor's prescription, the method of use and the
instruction of the pharmacist who sold the medicament.
- The doctor and the pharmacist are the experts in medicines, their
benefits and risks.
- Do not by yourselves interrupt the period of treatment prescribed
for you.
- Do not repeat the same prescription without consulting your doctor.
- Keep all medicaments out of reach of children
Council of Arab Health
Ministers
Union of Arab Pharmacists
g. This patient information leaflet is approved by the Saudi Food
and Drug Authority
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>تريفاستال ريتارد ٥٠، حبات ملبسة مديدة الإطلاق هو مقلّد للدوبامين (يعمل في الدماغ لتحفيز مستقبلات مادة تدعى دوبامين).</p><p>&nbsp;</p><p>يوصف هذا الدواء لمعالجة بعض أشكال داء باركنسون</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>أ. لا تتناول </strong><strong>تريفاستال ريتارد&nbsp;</strong><strong>٥٠</strong> في <strong>الحالات</strong> التالية:</p><p>&nbsp;</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من الحساسية تجاه مادة البيريبيديل</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كنت تعاني من احتشاءالقلب أو غيرها من الأمراض القلبية الوعائية الخطيرة،</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بالاشتراك مع مضادت القيء ومضادات الذهان (أنظر إلى قسم تناول أو استعمال الأدوية الأخرى).</p><p>إذا كان لديك أي شك، فاطلب نصيحة طبيبك أو مزوّد الرعاية الصحية أو الصيدلاني.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>ب. ينبغي أخذ الاحتياطات </strong><strong>الخاصة مع </strong><strong>تريفاستال ريتارد&nbsp;</strong><strong>٥٠</strong></p><p><strong>تحذيرات خاصة</strong></p><p>في حال أحسست بنعاس فائق أو نوم فجائي أثناء مدّة العلاج بواسطة تريفاستال ريتارد ٥٠، عليك بالإتصال</p><p>بطبيبك أو مزوّد الرعاية الصحية.</p><p>&nbsp;</p><p>أخبر طبيبك أو مزوّد الرعاية الصحية إذا لاحظت أنت أو أحد أفراد أسرتك/ أو من يعتني بك ظهور رغبات مفرطة أو اندفاعات لممارسة سلوكيات غير عادية بالنسبة إليك ولا يمكنك مقاومة الاندفاع للقيام بتصرفات معينة قد تسبب الأذى لك أو للآخرين. يطلق على هذه الحالات اسم اضطرابات التحكم بالاندفاع وهي تشمل سلوكيات كإدمان القمار، الأكل بشراهة أو الإنفاق بإسراف، رغبة جنسية عالية بشكل غير طبيعي أو ازدياد الأفكار أو المشاعر الجنسية. قد يحتاج طبيبك أو مزوّد الرعاية الصحية إلى تعديل جرعتك أو إيقافها.</p><p>&nbsp;</p><p>لدى المسنين، يجب أن توضع في الاعتبار إمكانية السقوط سواء كان على صلة بهبوط الضغط الشرياني أو ببدء النوم المفاجئ أو بحالة الارتباك.</p><p>&nbsp;</p><p>نظرا لوجود السكّروز في هذا الدواء، فلا يجوز إستعماله في حال عدم تحمل سكر الفاكهة، أو في حال متلازمة سوء إمتصاص الغالاكتوز، أو في حال نقص خميرة السكراز إيزومالتاز (أمراض إستقلابية نادرة).</p><p>&nbsp;</p><p><strong>تحذيرات للاستعمال</strong></p><p>يُستحسن إبتلاع الحبّات في نهاية الوجبات الغذائية.</p><p>إذا كان لديك أي شك، فلا تتردد في طلب نصيحة طبيبك أو مزوّد الرعاية الصحية أو الصيدلاني.</p><p>&nbsp;</p><p><strong>ج. </strong><strong>تناول الأدوية الأخرى، المكملات العشبية أو الغذائية:</strong></p><p>&nbsp;</p><p>يجب الامتناع عن استعمال هذا المستحضر الدوائي بالاشتراك مع بعض الأدوية الأخرى (أنظر إلى قسم أ. لا تتناول تريفاستال ريتارد ٥٠ في الحالات التالية).</p><p><strong>&nbsp;</strong></p><p>ولتفادي التفاعلات المتبادلة التي قد تنتج عن استعمال أدوية متعددة، وخاصة منها الأدوية المضادة للذهان (بإستثناء الكلوزابين)، تترابينازين، وبعض الأدوية المستعملة للوقاية من القيء والغثيان، والأدوية المنوّمة، يجب دائما إعلام الطبيب أو مزوّد الرعاية الصحية أو الصيدلاني عن أي دواء آخر تتناوله.</p><p>&nbsp;</p><p><strong>د. تناول </strong><strong>تريفاستال ريتارد&nbsp;</strong><strong>٥٠ مع الطعام والشراب:</strong></p><p>يوصى بتجنّب تعاطي الكحول أو المشروبات الكحولية إذا كنت تتناول هذا الدواء، فتأثيراته قد تزداد.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>هـ. </strong><strong>الحمل والإرضاع:</strong></p><p>يجب دائما استشارة الطبيب، مزوّد الرعاية الصحية أو الصيدلاني قبل المباشرة بتعاطي أي دواء.</p><p>&nbsp;</p><p><strong>و. قيادة السيارات واستعمال الآليات:</strong></p><p>قد يسبب إستعمال تريفاستال ريتارد ٥٠<strong> </strong>&nbsp;حدوث نعاس فائق ونوبات نوم مفاجيء.</p><p>إذا حدث هذا فلا يجوز أن تقود السيارات أو أن تمارس عملاً لا يتوافق وعدم اليقظة&nbsp; فقد تعرض نفسك والآخرين لإمكانية وقوع حوادث خطيرة أو الموت (مثل تشغيل الآليات) إلى أن تزول هذه التأثيرات. .</p><p>&nbsp;</p><p><strong>ز. معلومات هامة تتعلق ببعض مكونات </strong><strong>تريفاستال ريتارد</strong><strong>&nbsp;٥٠:</strong></p><p>يحتوي تريفاستال ريتارد ٥٠ على<strong> </strong>السكروز وصبغة أحمر القرمزة أ (إي ١٢٤) والصوديوم.</p><table cellspacing="0" cellpadding="0" align="left"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL">نظرا لاحتوائه على سكروز، يجب عدم استعمال هذا الدواء في حال عدم تحمل الفروكتوز، متلازمة سوء امتصاص الغلوكوز والغلاكتوز، أو عوز انزيم سكراز/ إيزومالتاز (اضطراب استقلابي نادر).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يوجد احتمال حساسية نظرًا لاحتواء الدواء على<strong> الأحمر القرمزي </strong>&Alpha;<strong> </strong><strong>(إي </strong><strong>١٢٤</strong><strong>).</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 ملغ) لكل قرص، لذا يمكن اعتباره &quot;بدون صوديوم&quot;.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>الجرعة</strong></p><p><strong>&nbsp;</strong></p><p>إن الجرعة تابعة لوضع كل فرد على حدة. وهي تُحدّد من قِبل الطبيب أو مزوّد الرعاية الصحية.</p><p>وفي شتى الأحوال عليك بالتقيد التام بوصفة الطبيب أو مزوّد الرعاية الصحية.</p><p><strong>&nbsp;</strong></p><p><strong>طريقة الإعطاء</strong></p><p>عن طريق الفم.</p><p>يجب أن تُبتلع الحبّات مع نصف كأس من الماء، دون مضغها، في نهاية وجبات الطعام.</p><p>تناول الدواء مع التقيد التام بالطريقة التي وصفها لك طبيبك أو مزوّد الرعاية الصحية.</p><p>لا تتوقف عن تناول العلاج دون إستشارة الطبيب.</p><p>&nbsp;</p><p><strong>أ. في حال تناول جرعة اكبر مما يبنبغي من </strong><strong>تريفاستال ريتارد&nbsp;</strong><strong>٥٠ </strong></p><p>في حال تناول كمية كبيرة هذا الدواء ، استشر &nbsp;طبيبك أو مزوّد الرعاية الصحية فوراً.</p><p><strong>&nbsp;</strong></p><p><strong>ب. في حال السهو عن تناول</strong><strong> تريفاستال ريتارد&nbsp;</strong><strong>٥٠</strong></p><p>لا تتناول جرعة مضاعفة للتعويض عن جرعة منسية، عليك فقط أن تأخذ الجرعة التالية في وقتها الطبيعي.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>ج. إذا توقفت عن تناول </strong><strong>تريفاستال ريتارد&nbsp;</strong><strong>٥٠:</strong></p><p>عليك التقيّد بوصفة الطبيب. ولا يجوز التوقف عن العلاج دون إستشارة الطبيب.</p><p>إذا كانت لديك أي أسئلة إضافية تتعلق باستعمال هذا الدواء، فاسأل طبيبك، مزوّد الرعاية الصحية، أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال مع كافة الأدوية، فقد تنتج آثار جانبيّة مع تريفاستال ريتارد ٥٠، رغم أنها لاتصيب كافة الأشخاص</p><p>&nbsp;</p><p>يتم تحديد معدل حدوث الآثار الجانبية المحتملة المبينة أدناه باستعمال القاعدة التالية:</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شائعة جدا (تحدث لدى أكثر من ١ من كل ١٠ أشخاص)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شائعة (تحدث لدى ١ إلى ١٠ أشخاص من كل١٠٠ شخص)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->غير شائعة (تحدث لدى ١ إلى ١٠ أشخاص من كل ١٠٠٠ شخص)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نادرة (تحدث لدى ١ إلى ١٠ أشخاص من١٠٠٠٠ شخص)&nbsp;</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نادرة جدا: قد تحدث لدى أقل من ١ من كل ١٠٠٠٠شخص)</p><p><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->غير معروفة المعدّل (لا يمكن تقدير معدل الحدوث بناءً على البيانات المتوفرة)</p><p>&nbsp;</p><p>تأثيرات جانبية شائعة</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إضطرابات هضمية خفيفة (غثيان، قيء، إنتفاخ في البطن)، يمكن إنقاصها بزيادة الجرعة تدريجيا</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ارتباك، هلاوس أو تهيّج عصبي يختفي عند إيقاف المعالجة،</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شعور بالدوار يختفي عند إيقاف المعالجة،</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نُعاس</p><p>&nbsp;</p><p>تأثيرات جانبية غير شائعة</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->هبوط الضغط الشرياني، هبوط الضغط الشرياني الإنتصابي (أي هبوط الضغط الشرياني وقت الوقوف)، عدم استقرار ضغط الدم الذي قد يترافق بالدوار أو التوعّك</p><p>&nbsp;</p><p>تأثيرات جانبية نادرة جدا:</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نعاس شديد أثناء النهار، نوبات نوم مفاجئ.</p><p>&nbsp;</p><p>عدم القدرة على مقاومة الاندفاع، أو الميل للقيام بأفعال قد تكون مؤذية لك أو للآخرين، والتي قد تشمل:</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->رغبة شديدة للمقامرة (بالمال) على الرغم من عواقبه الخطيرة الشخصية والأسرية.</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تغير أو ازدياد الميول والسلوكيات الجنسية بشكل يثير الاهتمام والقلق لديك ولدى الآخرين، كازدياد</p><p>الرغبة الجنسية مثلا.</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->المبالغة في الانفاق أو التسوق التي لا يمكن السيطرة عليها.</p><p><!--[if !supportLists]-->o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الأكل بشراهة (تناول كميات كبيرة من الطعام خلال فترة قصيرة) أو الاسراف بتناول الطعام (تناول</p><p>كميات أكثر من المعتاد وأكثر مما يكفي لإشباع الجوع).</p><p>&nbsp;</p><p><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بسبب وجود صبغة أحمر القرمزة أ (إي ١٢٤). إمكانية حدوث تفاعلات تحسسية.</p><p><strong>&nbsp;</strong></p><p><strong>الإبلاغ عن الآثار الثانوية</strong></p><p>إذا أصبت بأي آثار جانبية، فالرجاء إبلاغ طبيبك أو مزوّد الرعاية الصحية، الصيدلاني. وهذا ينطبق أيضا على أي آثار جانبية محتملة وإن لم يرد ذكرها في هذه النشرة.<strong> </strong>يمكنك أيضا الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق نظام الإبلاغ الوطني.</p><p>عند إبلاغك عن الآثار الجانبية فأنت تساعد بتقديم مزيد من المعلومات عن سلامة الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تدع الدواء في متناول يد الأطفال أو تحت نظرهم.</p><p>&nbsp;</p><p dir="RTL">يحفظ ضمن درجة حرارة لا تتجاوز ٢٥ درجة مئوية.</p><p>لا تستخدم &nbsp;تريفاستال ريتارد ٥٠، حبات ملبسة مديدة التحرير بعد تاريخ إنتهاء الفعاليّة المبيّن على العبوة الخارجيّة.</p><p>&nbsp;</p><p>&nbsp;لا تتخلص من الأدوية في مياه المجاري العامة أو مع قمامة المنزل.&nbsp; اسأل الصيدلاني عن طريقة</p><p>التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات تساعد على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أ. ما هي مكونات تريفاستال ريتارد ٥٠</p><p>المادة الفعالة هي:</p><p>&nbsp;بيريبيديل......................................... ٥٠ ملغ &nbsp;.</p><p>في كل حبّة ملبّسة واحدة مديدة التحرير</p><p>المكونات الأخرى هي<strong>:</strong></p><p>&nbsp;بوفيدون، ستيارات المغنيزيوم، طلق، ثاني كربونات الصوديوم، الكرملّوز الصودي، شمع النحل الأبيض، ثاني أوكسيد التيتانيوم (إي ١٧١)، صبغة ألومينية من أحمر القرمزة أ، متعدد الصوربات ٨٠، سكروز، السيليكا الغروانيّة اللامائيّة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>يتوفر تريفاستال ريتارد ٥٠ في علبة تحتوي على ٣٠ حبّة ملبّسة مديدة التحرير.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>الجهة الحاملة لترخيص التسويق</strong></p><p>Les Laboratoires Servier</p><p>50, rue Carnot</p><p>92284 Suresnes cedex</p><p>France</p><p>&nbsp;</p><p><strong>الجهة المصنعة</strong></p><p>Les Laboratoires Servier Industrie</p><p>905, route de Saran</p><p>45520 Gidy</p><p>France</p><p>&nbsp;</p><p>للحصول على أي معلومات تتعلق بهذا الدواء، الرجاء الاتصال بالوكيل المحلي للجهة الحاملة لإجازة التسويق.</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المملكة العربية السعودية</strong></p><p dir="RTL">المكتب العلمي لشركة سيرفير العربية السعودية</p><p dir="RTL">3533 الحوي ، حي حطين، مكتب 101</p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">هاتف: ٩٦٦١١٢٥٢٢٣٣٠+</p><p dir="RTL">البريد الالكتروني: regulatory.sa1@servier.com</p></td><td style="vertical-align:top"><p dir="RTL"><strong>بلدان الخليج</strong></p><p dir="RTL">المكتب العلمي لمختبرات سيرفييه</p><p dir="RTL">ص.ب. ١٥٨٦، الطابق 15، برج أرينكو، مدينة دبي الإعلامية</p><p dir="RTL">طريق الشيخ زايد، دبي، الإمارات العربية المتحدة</p><p dir="RTL">هاتف: ٩٧١٤٣٣٢٩٩٠٣+</p><p dir="RTL">البريد الالكتروني: <u>magdy.abdou@servier.com</u></p><p dir="RTL"><strong>&nbsp;</strong></p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة الأخيرة على هذه النشرة في 2-2023


للإبلاغ عن التأثير(ات) الجانبية:

•	المملكة العربية السعودية

- المركز الوطني للتيقظ الدوائي (NPC)
- للاتصال بالرقم الموحد للهيئة العامة للغذاء والدواء 19999
- البريد الالكتروني: npc.drug@sfda.gov.sa
- الموقع الالكتروني: https://ade.sfda.gov.sa/ 

•	دول الخليج العربي الأخرى:
- الرجاء الاتصال بالسلطات المختصة ذات الصلة.

مجلس وزراء الصحة العرب:

إن هذا لدواء
-	الدواء مستحضر يؤثر على صحّتك، واستهلاكه خلافاً للتعليمات يعرّضك للخطر.
-	تقيّد بوصفة الطبيب، وبطريقة الاستعمال المدوّنة، وبتعليمات الصيدلاني الذي صرف لك الدواء.
-	فالطبيب والصيدلاني هما الخبيران بالدواء ونفعه وضرره.
-	لا تقطع مدة العلاج الموصوفة لك من تلقاء نفسك.
-	لا تكرر استعمال نفس الدواء دون مراجعة الطبيب.
-	لا تدع الأدوية بمتناول أيدي الأطفال.
                                                      مجلس وزراء الصحّة العرب
                                               وإتّحاد الصيادلة العرب

هذه النشرة لمعلومات المريض حائزة على موافقة الهيئة العامة للغذاء والدواء في المملكة العربية السعودية
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trivastal Retard 50, sustained release coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Piribedil ............................. 50.00 mg
Excipients with known effects: sucrose, cochineal red A (E124)
For one prolonged-release coated tablet
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sustained release coated tablet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of Parkinson&#39;s disease:<br />either as single-agent therapy (treatment of essential forms with tremor), or in combination with levo-dopa, from the outset or secondarily, in particular in forms with tremor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Treatment of Parkinson&rsquo;s disease:<br />&bull; as monotherapy: 150 mg to 250 mg, i.e. 3 to 5 tablets daily, to be divided into 3 to 5 administrations per day.<br />&bull; as a supplement to dopatherapy: 100 to 150 mg, i.e. 2 to 3 tablets daily, to be divided into 2 to 3 administrations per day.<br />These doses must be attained gradually&nbsp;by increasing the dose one tablet at a time, with an interval between dose increases that may vary from three days to 2 weeks depending on the patient&#39;s condition and acceptability of the drug. The interval between dose increases should not be less than 3 days.<br />Discontinuation of treatment<br />Sudden discontinuation of dopamine agents may result in neuroleptic malignant syndrome. To avoid this risk the dose of piribedil must be reduced gradually until complete discontinuation of treatment.<br />Impulse control disorders<br />To avoid the risk of impulse control disorders, prescription of the minimum effective dose is recommended. Dose reduction or gradual discontinuation of treatment should be considered if such symptoms occur (see section 4.4).<br />Kidney or liver failure<br />Piribedil has not been studied in these groups of patients. It is recommended to treat these patients&nbsp;with caution.</p><p>Paediatric population<br />The safety and efficacy of piribedil in children under the age of 18 years have not been established. There is no available data. There is no justified use of piribedil in the paediatric population for this indication.<br />Method of administration<br />Oral route.<br />The tablets should be swallowed, without chewing, with half a glass of water at the end of the meal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicine is contraindicated in the following situations:
• hypersensitivity to piribedil or to any of the excipients listed in section 6.1,
• cardiovascular shock,
• acute phase of myocardial infarction,
• in association with anti-emetic neuroleptics (see section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dyskinesia:<br />In advanced stage Parkinson&rsquo;s disease, in conjunction with levodopa, dyskinesia may occur at the start of treatment with piribedil. In this case, the dose of piribedil should be reduced.<br />Orthostatic hypotension:<br />Dopamine agonists are known to alter systemic blood pressure regulation resulting in postural orthostatic hypotension.<br />Monitoring of blood pressure is recommended, particularly at the start of treatment, given the risk of orthostatic hypotension associated with dopamine treatment.<br />Abnormal behaviour:<br />Abnormal behaviour has been reported and may be associated with manifestations of confusion, agitation, aggression. Dose reduction or gradual discontinuation of treatment should be considered if such symptoms occur.<br />Sleep disorders:<br />Piribedil has been associated with somnolence and episodes of sudden sleep onset, particularly in patients with Parkinson&#39;s disease.<br />Sudden onset of sleep during daily activities, in some cases without awareness or warning signs, has been reported very rarely. Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment with piribedil. Patients who have experienced somnolence and/or an episode of sudden sleep onset must refrain from driving or operating machines. Furthermore, a reduction of dosage or termination of therapy may be considered.<br />Given the age of the population treated, the risk of falls, whether related to hypotension, sudden&nbsp;sleep onset or delirium, must be taken into account.</p><p>Impulse control disorders<br />The onset of impulse control disorders must be regularly monitored in these patients. The patients and those close to them must be informed of the behavioural symptoms of impulse control disorders such as: pathological gambling (compulsive gambling), hypersexuality, increased libido, compulsive spending or shopping, excessive consumption of food and compulsive food disorders, which may appear in patients treated with dopaminergic agonists including TRIVASTAL. A decrease of the doses or progressive discontinuation of the treatment must be envisaged if such symptoms appear.<br />Psychotic disorders<br />Dopamine agonists may cause or worsen psychotic disorders such as delusion, delirium, hallucinations (see section 4.5). Dose reduction or gradual discontinuation of treatment should be considered if such symptoms occur.<br />Peripheral oedema<br />Peripheral oedema has been observed during the use of dopamine agonists. This should be taken into account when prescribing piribedil.<br />Neuroleptic malignant syndrome<br />Characteristic symptoms of neuroleptic malignant syndrome have been reported following sudden discontinuation of dopamine treatment (see section 4.2).<br /><br />Excipients&nbsp;<br />Due to the presence of sucrose, patients with fructose intolerance, glucose - galactose malabsorption syndrome or sucrase-isomaltase insufficiency (rare hereditary diseases) should not take this medicine.<br />Due to the presence of cochineal red A (E124), there is a risk of allergic reactions (see section 4.8).<br />This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Contraindicated combinations<br />+ Antiemetic neuroleptics<br />Reciprocal antagonism between the dopaminergic agent and the neuroleptic. Use an anti-emetic without extrapyramidal effects.<br />Inadvisable combinations<br />+ Antipsychotic neuroleptics (except clozapine)<br />Reciprocal antagonism between the dopaminergic agent and the neuroleptics.<br />The dopaminergic agent can provoke or aggravate psychotic disorders. If a neuroleptic treatment is required in parkinsonian patients treated with dopaminergic agents, the latter must be gradually reduced until withdrawal (the sudden withdrawal of dopaminergic agents can expose to a &ldquo;neuroleptic malignant syndrome&rdquo; risk).<br />+ Tetrabenazine<br />Reciprocal antagonism between the dopaminergic agent and tetrabenazine.</p><p>+ Alcohol consumption<br />Alcohol increases the sedative effect of piribedil.<br />Impaired vigilance may make driving vehicles and the use of machinery dangerous.<br />Combination to be taken into account:<br />+ Other sedatives<br />Increase in central depression.<br />The impairment of alertness could make driving and using machines dangerous.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />The available data in mice show piribedil passes through the placental barrier, and is distributed in foetal organs.<br />In the absence of relevant data, the use of this drug during pregnancy and in women of childbearing age not using contraception is not recommended.<br />Lactation<br />In the absence of relevant data, the use of this drug during breastfeeding is not recommended.<br />Fertility<br />Studies conducted in animals have not shown any direct or indirect harmful effects on embryonic/foetal<br />development, parturition or post-natal development.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients being treated with piribedil and presenting with somnolence and/or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. operating machines) until such recurrent episodes and somnolence have resolved (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects have been observed during treatment with piribedil and ranked under the following frequency:<br />Very common (&ge;1/10); common (&ge; 1/100, &lt; 1/10); uncommon (&ge; 1/1000, &lt; 1/100);<br />rare (&ge; 1/10000, &lt; 1/1000); very rare (&lt; 1/10000), not known (cannot be estimated from the available data).<br />The following signs may appear:<br />Gastrointestinal disorders<br />&bull; Common: minor gastrointestinal disorders (nausea, vomiting, flatulence) which may disappear, particularly if the individual dose is adjusted (gastro-intestinal symptoms can be greatly reduced by stepwise uptitration: 50 mg increase every 2 weeks).<br />Psychiatric disorders<br />&bull; Common: psychic disorders such as confusion, hallucinations (visual, auditory, mixed) or agitation have been observed, which disappear when treatment is stopped.<br />&bull; Unknown frequency: aggression, psychotic disorders (delusion, delirium).</p><p>&bull; Impulse control disorders<br />Symptoms such as: pathological gambling (compulsive gambling), hypersexuality, increased libido, compulsive spending or shopping, excessive consumption of food and compulsive food disorders may appear in patients treated with dopaminergic agonists including TRIVASTAL (see sections 4.2 and 4.4).<br />Nervous system disorders<br />&bull; Common: dizziness has been observed which disappears when treatment is stopped.<br />&bull; Unknown frequency: dyskinesia<br />&bull; Piribedil is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep onset episodes.<br />Cardiovascular disorders<br />&bull; Uncommon: hypotension, orthostatic hypotension, unstable blood pressure causing syncope or malaise.<br />General disorders and anomalies at the administration site<br />&bull; Unknown frequency: peripheral oedema<br />&bull; Risk of allergic reactions due to the presence of Cochineal red A (E124).<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system of SFDA&ndash;</p><ul><li>Saudi Arabia:</li></ul><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>-&nbsp; National Pharmacovigilance Center (NPC)</p><p>- Fax: +966-11-205-7662</p><p>- SFDA call Center 19999</p><p>-&nbsp; Toll free phone: 8002490000</p><p>-&nbsp; E-mail: &nbsp;npc.drug@sfda.gov.sa</p><p>-&nbsp; Website: &nbsp;www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p><ul><li>Other GCC states:</li></ul><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>- Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Given the emetic effect of piribedil at very high doses, overdosage is unlikely with the tablet form.<br />The signs of overdose are:<br />&bull; blood pressure instability (arterial hypertension or hypotension),<br />&bull; digestive symptoms (nausea, vomiting).<br />These symptoms disappear on discontinuation of administration and with symptomatic treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: DOPAMINERGIC AGONISTS, ATC Code: N04BC08<br />Mechanism of action:<br />Piribedil: dopaminergic agonist (stimulates dopamine receptors and the cerebral dopaminergic pathways). In humans, the mechanism of action is demonstrated by the clinical pharmacology studies:<br />&bull; stimulation of &ldquo;dopaminergic&rdquo; type cortical electrogenesis both while awake<br />and during sleep,<br />&bull; clinical activity on the different functions controlled by dopamine, with this activity being demonstrated via the use of behavioural or psychometric scales.<br />In addition, piribedil results in an increase in femoral blood flow (the existence of dopaminergic receptors in the femoral vascular bed explains the action of piribedil on peripheral circulation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Piribedil is absorbed rapidly.<br />Distribution<br />The maximum concentration is reached one hour after oral administration of piribedil. Plasma elimination is biphasic and is composed of a first phase characterised by a half-life of 1.7 hours and a second, slower phase characterised by a half-life of 6.9 hours.<br />Biotransformation<br />Metabolism of piribedil is intense, with two main metabolites (a hydroxylated derivative and a dihydroxylated derivative).<br />Elimination<br />Piribedil is excreted essentially in the urine: 68% of the piribedil absorbed is excreted by the renal route in the form of metabolites and 25% is excreted in bile.<br />Pharmacokinetic/pharmacodynamic correlations<br />The prolonged-release tablet containing 50 mg of piribedil allows in vivo gradual absorption and release of the active ingredient.<br />The kinetic studies conducted in humans show extension of the therapeutic coverage which exceeds<br />24 hours.<br />Urinary excretion is approximately 50% at the 24th hour and is total at the 48th hour.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Subchronic or chronic administration of piribedil has been well-tolerated in animals. No teratogenic potential has been demonstrated for piribedil in animals. In vitro and in vivo tests have shown no genotoxic potential. No carcinogenicity studies have been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Povidone, magnesium stearate, talc, sodium hydrogen carbonate, carmellose sodium, white beeswax, titanium dioxide (E171), cochineal red A aluminium lake (E124), polysorbate 80, sucrose, anhydrous colloidal silica.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10, 20, 30, 40, 50, 60 or 100 tablets in blisters (PVC/Aluminium).<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LES LABORATOIRES SERVIER
50, RUE CARNOT
92284 SURESNES CEDEX
FRANCE
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                02.2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>